Making sense of S3 therapeutic vapes: What do pharmacists need to know?
Following the 1 October commencement of S3 supply of therapeutic vapes and the release of the PSA and RACGP guidelines we are beginning to get clarity on what the supply of therapeutic vapes looks like for pharmacists.
Please join us as we provide a breakdown on what the 1 October changes really mean for your pharmacy.
Liber Pharmaceuticals has worked closely with thousands of pharmacists and prescribers for the last three years to ensure that you are able to supply therapeutic vapes effectively.
Join us as we share our thoughts on the following:
- An update on the new regulatory and market landscape
- What the PSA and RACGP guidance mean for pharmacists
- Conflicts between Federal and State vaping regulations
- Checklist – does your pharmacy have everything in place?
Plus, each session will have at least 30 minutes for open Q&A.
This content is gated for Australian healthcare professionals only
It is an offence to falsely claim to be a registered practitioner, to use a protected title, and/or to use symbols or language that may lead a reasonable person to believe that you are a registered health practitioner or are qualified to practice in a health profession.
Healthcare professional?
Register now for full access
Pharmacist education modules
featured module
Dispensing low concentration NVPs (Schedule 3)
Request a free pharmacy pack
Speak to a Liber representative
Liber:Onboard
Whitney Kabel
Head of Medical Liaison
- external link (hubspot.com)
Liber:Activate
- external link (liber.com.au)